Pediatric ADHD

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

Videos

Can Lifestyle Interventions Reduce the Risk of Children Developing ADHD?

11/12/2020

In this video, Vladimir Maletic, MD, MS, discusses whether lifestyle interventions can help reduce the risk of children developing attention deficit/hyperactivity disorder (ADHD).

In this video, Vladimir Maletic,...

11/12/2020

Psych Congress Network

Videos

Improving Outcomes in ADHD Through Early Treatment

09/23/2020

Psych Congress 2020 presenter c, discusses the ways in which early treatment can improve outcomes in patients with attention-deficit/hyperactivity disorder (ADHD).

Psych Congress 2020 presenter c,...

09/23/2020

Psych Congress Network

Videos

Treating Comorbidities in Patients With ADHD

09/22/2020

Psych Congress 2020 cochair Vladimir Maletic, MD, MS, discusses the risks associated with comorbid conditions in patients with attention deficit/hyperactivity disorder (ADHD) and strategies for treating them.

Psych Congress 2020 cochair...

09/22/2020

Psych Congress Network

Videos

Should You Start ADHD Treatment With a Stimulant or Nonstimulant?

08/26/2019

When a patient is newly diagnosed with attention-deficit/hyperactivity disorder (ADHD), is it better to begin treatment with a stimulant or a nonstimulant? Anthony L. Rostain, MD, MA, shares his thoughts in this video.

When a patient is newly...

08/26/2019

Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Pediatric ADHD Excellence Forum

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products